NCT01303692View on ClinicalTrials.gov

Comparison of Bone Mineral Loss in Prostate Cancer Patients Who is Receiving GnRH Agonist and -Plus Anti-androgen Agent

CompletedOBSERVATIONAL
Enrollment

312

Participants

Timeline

Start Date

April 30, 2011

Primary Completion Date

February 28, 2014

Study Completion Date

February 28, 2014

Conditions
GnRH Agonist Alone vs. GnRH Agonist Plus Anti-androgen Combination Treated Prostate Cancer Patients
Trial Locations (2)

Unknown

Research Site, Seongnam-si

Research Site, Seoul

Sponsors

Lead Sponsor

AstraZeneca
All Listed Sponsors
lead

AstraZeneca

INDUSTRY